Celldex (CLDX) Tops Q2 EPS by 4c

Celldex (NASDAQ: CLDX) reported Q2 EPS of ($0.23), $0.04 better than the analyst estimate of ($0.27). Revenue for the quarter came in at $3.83 million versus the consensus estimate of $1.05 million.

For earnings history and earnings-related data on Celldex (CLDX) click here.

You May Also Be Interested In

• Worthington Steel, Inc. (WS) Misses Q4 EPS by 3c
• Raymond James Starts Tonix Pharma (TNXP) at Strong Buy
• Micron Technology (MU) Tops Q3 EPS by $4.62, Guidance Beats